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Background: Fatigue is the most commonly reported symptom in patients with persistent complaints following COVID-19 (ie,
long COVID). Longitudinal studies examining the intensity of fatigue and differentiating between physical and mental fatigue
are lacking.
Objective: The objectives of this study were to (1) assess the severity of fatigue over time in members of online long COVID
peer support groups, and (2) assess whether members of these groups experienced mental fatigue, physical fatigue, or both.
Methods: A 2-wave web-based follow-up study was conducted in members of online long COVID peer support groups with a
confirmed diagnosis approximately 3 and 6 months after the onset of infectious symptoms. Demographics, COVID-19 diagnosis,
received health care (from medical professionals or allied health care professionals), fatigue (Checklist Individual Strength–subscale
subjective fatigue [CIS-Fatigue]; 8-56 points), and physical and mental fatigue (self-constructed questions; 3-21 points) were
assessed. Higher scores indicated more severe fatigue. A CIS-Fatigue score ≥36 points was used to qualify patients as having
severe fatigue.
Results: A total of 239 patients with polymerase chain reaction/computed tomography–confirmed COVID-19 completed the
survey 10 weeks (SD 2) and 23 weeks (SD 2) after onset of infectious symptoms, respectively (T1 and T2). Of these 239 patients,
198 (82.8%) were women; 142 (59.4%) had no self-reported pre-existing comorbidities; 208 (87%) self-reported being in good
health before contracting COVID-19; and 62 (25.9%) were hospitalized during acute infection. The median age was 50 years
(IQR 39-56). The vast majority of patients had severe fatigue at T1 and T2 (n=204, 85.4%, and n=188, 78.7%, respectively). No
significant differences were found in the prevalence of normal, mild, and severe fatigue between T1 and T2 (P=.12). The median
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CIS-Fatigue score was 48 points (IQR 42-53) at T1, and it decreased from T1 to T2 (median change: –2 points, IQR –7 to 3;
P<.001). At T1, a median physical fatigue score of 19 points (IQR 16-20) and a median mental fatigue score of 15 points (IQR
10-17) were reported; these scores were lower at T2 for physical but not for mental fatigue (median change for physical fatigue
–1 point, IQR –3 to 0, P<.001; median change for mental fatigue 0 points, IQR –3 to 3, P=.52). At the time of completing the
follow-up survey, 194/239 (81.2%) and 164/239 (68.6%) of all patients had received care from at least one medical professional
and one allied health care professional, respectively.
Conclusions: Fatigue in members of online long COVID support groups with a confirmed COVID-19 diagnosis decreases from
10 to 23 weeks after onset of symptoms. Despite this, severe fatigue remains highly prevalent. Both physical and mental fatigue
are present. It remains unclear whether and to what extent fatigue will resolve spontaneously in the longer term.
Trial Registration: Netherlands Trial Register NTR8705; https://www.trialregister.nl/trial/8705.
(J Med Internet Res 2021;23(9):e30274) doi: 10.2196/30274
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Introduction
As the current COVID-19 pandemic continues to evolve, its
impact becomes apparent. Clinical studies of hospitalized,
laboratory-confirmed patients have shown that the acute phase
of COVID-19 is characterized by a large array of respiratory
and non-respiratory symptoms [1]. Over time, it has become
clear that not all previously hospitalized patients fully recover
from these symptoms in the months after the infection [2,3]. In
addition, nonhospitalized patients can present persistent
complaints months after the onset of infection-related symptoms
[4]. These long-lasting symptoms after COVID-19 are referred
to as long COVID [5], “a condition whereby affected individuals
do not recover for several weeks or months following the onset
of symptoms suggestive of COVID-19” [6], and they have a
major impact on patients’ quality of life (QoL) [7,8], care
dependency [9], work participation [10,11], day-to-day
activities, and physical functioning [12-14].
Fatigue, defined as “a subjective, unpleasant symptom which
incorporates total body feelings ranging from tiredness to
exhaustion creating an unrelenting overall condition which
interferes with individuals’ ability to function to their normal
capacity” [15], is the most commonly reported symptom in
patients with long COVID [2-4,16]. Similarly, other infections,
such as severe acute respiratory syndrome (SARS) [17,18],
Middle East respiratory syndrome (MERS) [19], and Q fever
[20] have previously been linked to long-term fatigue, often
referred to as postviral fatigue syndrome. Existing literature
suggests that fatigue has several clinical presentations. A
common distinction is made between physical fatigue (ie,
difficulty performing physical activities) and mental fatigue (ie,
difficulties concentrating and performing cognitive tasks) [21].
To date, longitudinal studies that examine fatigue intensity in
patients with long COVID are lacking. Moreover, it is not
known whether patients experience mostly mental or physical
fatigue during and after the infection. Therefore, the objectives
of this study were to (1) assess the severity of fatigue over time
in members of online long COVID peer support groups; and
(2) assess whether members of online long COVID peer support
groups experience mental fatigue, physical fatigue, or both. We
hypothesized that fatigue would be common and persistent and
that both physical and mental fatigue would be present in
patients with long COVID.
Methods
Study Design and Participants
This study is a prospective web-based survey of members of
two Facebook peer support groups for patients with long COVID
in the Netherlands (approximately 11,000 members; [22]) and
Flanders (Belgium, approximately 1200 members; [23]), and a
panel of approximately 1200 people who registered at a website
of the Netherlands Lung Foundation (coronaplein [24]), an
online platform providing additional information, advice, and
peer support. Note that these totals represent the number of
members of each group at the period of data collection. Between
June 4 and June 11, 2020 (the time point of completing the first
survey [T1]), members were invited to complete a web-based
survey. Participants who completed the first survey [4,8,9] and
who agreed to be contacted for a follow-up study received a
second survey between August 31 and September 8, 2020 (ie,
approximately three months after the first survey; the time point
of completing the second survey [T2]). Ethical approval for this
study was waived by the medical ethics committee of Maastricht
University because the Medical Research Involving Human
Subjects Act (WMO) does not apply to this study
(METC2020-1978 and METC2020-2254). The medical ethics
committee of Hasselt University formally judged and approved
the study (MEC2020/041). Digital informed consent was
obtained twice from all respondents (at the start of each survey).
Exclusion criteria were intensive care unit (ICU) admission
during the acute phase of infection, an onset of symptoms before
January 1, 2020, being in the acute phase of COVID-19 when
answering the first survey (ie, onset of infectious symptoms
less than 3 weeks before filling out the first survey [25]), or an
incomplete survey. Cross-sectional and follow-up data from
this study on persistent symptoms, QoL, care dependency,
construct-validity of the post–COVID-19 functional status scale,
and information and care needs of members of online long
COVID peer support groups have been published before
[4,8,9,11,26,27]. This 2-wave web-based follow-up study was
registered at the Netherlands Trial Registry (NTR8705). The
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Strengthening the Reporting of Observational Studies in
Epidemiology (STROBE) checklist was used to guide reporting
[28]. Of note: the current study focusses on patients with a
confirmed COVID-19 diagnosis (ie, test-diagnosed cases). The
results for the patients without a confirmed COVID-19 diagnosis
are presented in Multimedia Appendix 1.
Assessment via Web-Based Surveys
The survey was developed in close collaboration with scientists,
methodologists, health care professionals and COVID-19
patients from the long COVID peer support groups (the
Netherlands and Flanders). It was digitalized by ASolutions
[29] and was made available via their online platform. The
survey consisted of general questions regarding demographics,
clinical characteristics, and standardized questionnaires,
including a fatigue questionnaire.
Demographic and Clinical Characteristics
Respondents received questions regarding demographical
aspects such as gender, age, weight, height, educational level
(low/medium/high; classification according to the International
Standard Classification of Education 2011 [30]), and
married/living with a partner (yes/no). In addition, the following
clinical characteristics were assessed via self-report: pre-existing
comorbidities (see Multimedia Appendix 2), health status
(good/moderate/poor) during the infection and at the moment
of completing the surveys, date of symptom onset, symptoms
during acute phase of COVID-19 and at the moment of
completing the surveys (see Multimedia Appendix 2),
COVID-19–related hospitalization, and COVID-19 diagnosis
(based on reverse transcription polymerase chain reaction (PCR)
test or computed tomography (CT) scan of the
thorax/symptom-based medical diagnosis by a physician/no
formal test or diagnosis). Based upon the latter, patients were
classified as either “test-diagnosed” COVID-19 (PCR or CT)
or “presumed” COVID-19 (physician-diagnosed or no formal
diagnosis/testing).
Received Health Care
Information regarding received health care (yes/no) by a medical
professional (eg, medical specialist; general practitioner [GP];
nurse) or an allied health care professional (AHP; eg,
physiotherapist [PT]; psychologist; occupational therapist [OT];
dietician; speech and language therapist) was recorded.
Standardized Fatigue Questionnaire
Fatigue, the primary outcome measure, was measured using a
subscale of the Checklist Individual Strength (CIS). The
Checklist Individual Strength–subscale subjective fatigue
(CIS-Fatigue) is a standardized questionnaire [31,32] with high
internal consistency and test-retest reliability; good discriminant,
concurrent and criterion validity; and ability to detect change
in subjective fatigue [33-37]. The questionnaire consists of 8
items scored on a 7-point Likert scale. Scores range from 8 to
56 points, and a higher score indicates more clinical symptoms
of general fatigue (see Multimedia Appendix 3 for the
CIS-Fatigue questionnaire) [31,32]. Based upon validated cutoff
values, individuals can be classified as having normal (≤26
points), mild (27-35 points), and severe (≥36 points) fatigue
[31-33].
Self-constructed Physical and Mental Fatigue Questions
A total of 3 self-constructed questions (all part of the
CIS-Fatigue subscale) were used to evaluate physical fatigue
(“Physically I feel exhausted,” “Physically I feel I am in a bad
condition,” and “Physically I feel in a good shape”). In addition,
to differentiate between physical and mental fatigue, 3 questions
were constructed in which the word “physically” was replaced
by the word “mentally” (“Mentally I feel exhausted,” “Mentally
I feel I am in a bad condition,” and “Mentally I feel in a good
shape,” respectively) to estimate mental fatigue. The physical
and mental fatigue questions were scored on a 7-point Likert
scale, with scores ranging from 3 to 21 points. A higher score
indicates worse physical and mental fatigue, respectively. These
self-constructed physical and mental fatigue questions and
explanations of the scoring are reported in Multimedia Appendix
4.
Statistical Analyses
Data are presented as means and standard deviations, medians,
and interquartile ranges or as frequencies and proportions, where
appropriate. Differences over time were analyzed by a paired
t-test (or Wilcoxon signed-rank test) in continuous data and a
McNemar test (or McNemar-Bowker test) in categorical data.
If significant, a post hoc comparison of the McNemar-Bowker
test was performed, and significant Bonferroni-adjusted P values
were generated as corrections for multiple comparison.
Statistical analyses were conducted using SPSS 25.0 (IBM
Corporation). Figures were generated via GraphPad Prism 8.3.5
(GraphPad Software) and SankeyMATIC [38]. The level of
significance was set at .01 for all statistical tests (two-tailed).
Results
Participants’ Inclusion
In total, 2159 members of online long COVID peer support
groups filled out the first survey, of which 220 were excluded
for being in the acute phase of COVID-19 (n=14), ICU
admission during the acute phase of COVID-19 (n=15), onset
of symptoms before January 1, 2020 (n=8), and an incomplete
first survey (n=183). From the 1939 patients who were included,
1556 consented to be approached for follow-up research, of
which 1005 (64.6%) completed the second survey. Patients who
did not respond to the second survey were younger and more
often had a presumed COVID-19 diagnosis. Further details can
be found in a previously published paper [11]. The 1005 patients
completed the surveys on average 11.3 weeks (SD 2.2) and 23.5
weeks (SD 2.2) after onset of symptoms (T1 and T2,
respectively). Overall, 239 test-diagnosed (hospitalized, n=62,
and nonhospitalized, n=177) and 766 presumed
(physician-diagnosed, n=454, and patients with no formal
diagnosis/testing, n=312) patients with COVID-19 participated
in this 2-wave web-based survey (see Multimedia Appendix 5
for the flowchart).
Demographical and Clinical Characteristics
Patients with confirmed COVID-19 were mostly middle-aged
women (median age 50.0 years, IQR 39.0-56.0; 198/239 women,
82.8%) with a BMI indicating slight overweight (median BMI
26.0 kg/m2, IQR 23.4-30.5), and they completed the first (T1)
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and second (T2) survey on average 10.4 weeks (SD 2.4) and
22.6 weeks (SD 2.4) after onset of symptoms. Approximately
1 out of 4 patients (62/239, 25.9%) was hospitalized during the
acute phase of COVID-19. The majority of respondents had no
self-reported comorbidities (142/239, 59.4%) and good
self-reported health status before the infection (208/239, 87%).
Moreover, at T1 and T2, a minority of respondents self-reported
good health (22/239, 9.2%, and 40/239, 16.7%, respectively
[11]). Furthermore, patients retrospectively reported a median
of 15 symptoms (IQR 11-18) during the acute phase of
COVID-19, and 6 symptoms (IQR 4-9) and 6 symptoms (IQR
3-8) at T1 and T2, respectively. All details regarding patient
characteristics can be found in Table 1.
Table 1. Characteristics of patients with confirmed COVID-19 (n=239).
ValueCharacteristic
198 (82.8)Women, n (%)
50.0 (39.0-56.0)Age (years), median (IQR)
26.0 (23.4-30.5)BMI (kg/m2), median (IQR)
10.4 (2.4)Time between onset of symptoms and T1a survey (weeks), mean (SD)
22.6 (2.4)Time between onset of symptoms and T2b survey (weeks), mean (SD)
173 (72.4)Married/living with partner, n (%)
















Number of symptoms, median (IQR)
15 (11-18)During acute infection
6 (4-9)At T1
6 (3-8)At T2
62 (25.9)Hospitalized during acute infection, n (%)
aT1: time of completing the first survey.
bT2: time of completing the second survey.
Received Health Care
During the first 10 weeks after the onset of symptoms, 2 out of
3 patients (157/239, 65.7%) received or sought care from at
least one medical professional (GP: 139/239, 58.2%; medical
specialist: 73/239, 30.5%; nurse: 18/239, 7.5%), whereas 1 out
of 3 (90/239, 37.7%) received or sought care from at least one
allied health care professional (PT: 76/239, 31.8%; psychologist:
27/239, 11.3%; OT: 7/239, 2.9%, dietician: 25/239, 10.5%; and
speech and language therapist: 6/239, 2.5%). The cumulative
proportion of patients who received care from a medical
professional and allied health care professional at T2
respectively increased significantly to 81.2% (194/239; GP:
170/239, 71.1%; medical specialist: 131/239, 54.8%; nurse:
32/239, 13.4%; all P<.001) and 68.6% (164/239; PT: 157/239,
65.7%; psychologist: 55/239, 23%; OT: 27/239, 11.3%;
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dietician, 51/239, 21.3%; speech and language therapist, 21/239,
8.8%; all P<.001). Furthermore, the cumulative proportion of
patients who participated in an interdisciplinary rehabilitation
program (in- or outpatient) increased significantly from T1 to
T2 (10/239, 4.2%, to 32/239, 13.4%, respectively; P<.001).
Details regarding received health care can be found in Table 2.
Table 2. Fatigue-related measures and received health care in patients with confirmed COVID-19 at on average 10 weeks (T1) and 23 weeks (T2) after




<.00146 (37-50)48 (42-53)General fatigue (points on CIS-Fatiguec scale), median (IQR)
.03188 (78.7)204 (85.4)Severe fatigue, n (%)
.5214 (10-17)15 (10-17)Mental fatigue (points on self-constructed questions), median (IQR)
<.00118 (14-19)19 (16-20)Physical fatigue (points on self-constructed questions), median (IQR)
Received health care from a medical professional, n (%)
<.001194 (81.2)157 (65.7)Received care from ≥1 medical professionals
<.001170 (71.1)139 (58.2)General practitioner
<.001131 (54.8)73 (30.5)Medical specialist
<.00132 (13.4)18 (7.5)Nurse
Received health care from an allied health care provider, n (%)
<.001164 (68.6)90 (37.7)Received care from ≥1 allied health care providers
<.001157 (65.7)76 (31.8)Physiotherapist
<.00155 (23)27 (11.3)Psychologist
<.00127 (11.3)7 (2.9)Occupational therapist
<.00151 (21.3)25 (10.5)Dietician
<.00121 (8.8)6 (2.5)Speech and language therapist
<.00132 (13.4)10 (4.2)Rehabilitation (in- or outpatient), n (%)
aT1: time of completing the first survey.
bT2: time of completing the second survey.
cCIS-Fatigue: Checklist Individual Strength–subscale subjective fatigue.
Standardized Fatigue Questionnaire
Patients with confirmed COVID-19 reported a median
CIS-Fatigue score of 48 points (IQR 42-53) at T1. The majority
(204/239, 85.4%) reported severe fatigue at approximately 3
months after the onset of COVID-19 symptoms. The median
CIS-Fatigue score improved significantly between T1 and T2
(median change –2 points, IQR –7 to 3; P<.001) (Table 2),
whereas no significant differences were found in the proportions
of normal, mild, or severe fatigue (P=.12). An overview of the
proportions of patients with normal, mild, and severe fatigue at
T1 and T2, the proportional flow, and the direction of change
can be found in Figure 1. In addition, Multimedia Appendix 6
shows the proportion, flow, and direction of the change of
fatigue stratified for the type of diagnosis (ie, hospitalized and
nonhospitalized test-diagnosed patients, physician-diagnosed
patients, and patients without a formal diagnosis/test).
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Figure 1. Prevalence and change in fatigue in patients with long COVID who have confirmed COVID-19, measured using the CIS-Fatigue scale at on
average 10 (T1) and 23 (T2) weeks after onset of symptoms (n=239). The width of the lines is proportional to the flow rate. No significant change in
the prevalence of normal (≤26 points), mild (27-35 points), or severe (≥36 points) fatigue was found between T1 and T2 (McNemar-Bowker test, P=.12).
CIS-Fatigue: Checklist Individual Strength–subscale subjective fatigue; T1: time of completing the first survey; T2: time of completing the second
survey.
Self-constructed Physical and Mental Fatigue
Questions
Patients with confirmed COVID-19 reported median physical
and mental fatigue scores of 19 points (IQR 16-20) and 15 points
(IQR 10-17) at T1. Between T1 and T2, a significant decrease
was found in physical fatigue score (median change –1 point,
IQR –3 to 0; P<.001), but not in mental fatigue score (median
change 0 points, IQR –3 to 3; P=.52) (Table 2). Figure 2 shows
the distributions of patients across the spectrum of physical and
mental fatigue at T1 and T2.
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Figure 2. The distribution of patients with long COVID who have confirmed COVID-19 across the spectrum of self-constructed mental (left) and
physical (right) fatigue at on average 10 (T1) and 23 (T2) weeks after onset of symptoms (n=239). Scores range from 3 to 21 points, and higher scores
indicate higher levels of fatigue. T1: time of completing the first survey; T2: time of completing the second survey.
Discussion
Principal Findings
To the best of our knowledge, this is the first study to measure
fatigue over time in members from online long COVID peer
support groups with confirmed COVID-19 using a validated
and standardized measurement with generic cutoff values to
determine normal, mild, and severe fatigue. Our study indicates
that severe fatigue is highly prevalent in patients with long
COVID at approximately 3 and 6 months after the infection.
Furthermore, our longitudinal follow-up data suggest that fatigue
does not resolve over time in all patients, even if they receive
health care. In addition, patients experience both physical and
mental fatigue.
Fatigue is the most prominent symptom in patients with long
COVID [2,4], irrespective of the severity of the initial infection
[14]. Nevertheless, most studies are cross-sectional and use a
binary question (eg, fatigued/not fatigued) to assess the
prevalence of fatigue [2,16,39]. Therefore, little is known about
the change in fatigue intensity over time [14,40]. Our study
used a validated and standardized questionnaire to assess fatigue
and was able to quantify fatigue intensity. Indeed, fatigue is
highly prevalent in our sample. Moreover, fatigue was reported
to be generally high. The median fatigue scores found in our
sample are equal to or higher than those of other chronic diseases
that are characterized by fatigue, such as chronic obstructive
pulmonary disease [41], asthma [42], Q fever [20], multiple
sclerosis [43], rheumatoid arthritis [44], or systemic sclerosis
[45]. These findings are remarkable for such a young population
with few self-reported comorbidities and good self-reported
health status before the infection. Previously, other viral and
nonviral infections have been linked to prolonged and
debilitating fatigue [20,46-50]. For example, Lam and colleagues
investigated long-term complaints in SARS survivors and found
that approximately one-third of SARS survivors met the
modified 1994 US Centers for Disease Control and Prevention
criteria for chronic fatigue syndrome more than 3 years after
having SARS [17]. Moreover, MERS survivors often experience
chronic fatigue [19]. For patients with long COVID, it remains
unclear whether fatigue will resolve spontaneously in the longer
term. Our follow-up data show little to no improvement in the
proportion of patients with severe fatigue between 3 and 6
months, despite receiving medical and allied health care.
Consequently, almost two-thirds of the patients in our sample
are progressing toward chronic fatigue (ie, severe fatigue that
persists longer than six months [51]). The fact that some patients
may experience debilitating chronic fatigue is worrisome and
could have a major long-term impact upon these individuals as
well as on the health care system and society as a whole
[10,11,52]. Indeed, fatigue is strongly related to health-related
QoL and aspects of day-to-day life [14,25,53,54], and it often
involves sick leave, increased health care consumption, and
more hidden costs, such as informal care by friends or family
members [55-57].
Fatigue is a complex and challenging symptom, as multiple
factors can play a role in the initiation and maintenance of
fatigue, as seen in other chronic diseases [58]. It can present
itself as mental fatigue, physical fatigue, or both [40]. Therefore,
a patient-tailored treatment based upon a holistic and
comprehensive assessment of systemic, physical, psychological,
and behavioral factors is proposed to alleviate the fatigue
symptom burden [59]. To date, it remains unknown which
treatment strategies are effective to improve fatigue in patients
with long COVID. Several treatment strategies for fatigue are
proposed based upon knowledge from the fast-growing evidence
regarding COVID-19 and other pathologies, such as
multidisciplinary rehabilitation, energy conservation techniques,
pacing, cognitive behavioral therapy, graded exercise therapy,
or physical training [25,54,60-65]. Future research needs to
provide evidence regarding underlying pathways, evaluate the
effectiveness of existing treatment strategies, and identify
susceptible candidates, as it is expected that not everyone will
benefit from the same treatment strategy due to the multifactorial
nature of fatigue. Moreover, anecdotal evidence shows that
patients report having within-day and between-day variations
in their daily symptoms, including fatigue [54,66,67]; these
cannot be captured in detail by completing a questionnaire once
or twice over a longer period of time. In this, the use of an
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ecological momentary assessment may be valuable, as this
approach involves repeated measurements of the participant’s
symptoms, behavior, and context in vivo and in real time [68].
More insights in diurnal variation in fatigue and its association
with other symptoms may be useful in the development of more
tailored treatment strategies for fatigue in patients with long
COVID.
Methodological Considerations and Limitations
The current study has several limitations. First, the survey was
only made available to members of online long COVID peer
support groups. This probably caused selection bias, as it is
reasonable to assume that patients with high symptom burden
are more likely to become members of online long COVID peer
support groups. Second, all results were collected using a
web-based survey. Therefore, besides the self-reported
symptoms, the patients’height, body weight, and medical status
before and during the infection were also based on self-report,
which may have affected the internal validity of the current
findings to some extent. Recently, the National Institute for
Health and Care Excellence [69] proposed a case definition of
long COVID whereby alternative diagnosis should be excluded
when identifying patients with long COVID. Due to the nature
and timing of this study (ie, early phase of the pandemic), this
was not possible in the current study. Third, approximately 1
out of 3 participants who consented to be approached for
follow-up research did not respond to the second wave of the
survey. The authors have no information about the possible
reasons for not responding to the second wave of the survey,
although a between-group comparison was made to find possible
differences [11]. Fourth, the majority of our sample were
women, which limits our external validity. Nevertheless,
evidence is growing that women are more prone to develop long
COVID [70]. Fifth, self-constructed questions were used to
quantify mental fatigue, although validated questionnaires (such
as the Chalder fatigue index) to assess mental (and physical)
fatigue are available [71]. Therefore, no definite conclusions
on the burden of mental fatigue in online long COVID peer
support groups can be drawn based on the current study.
Nevertheless, the current results indicate that COVID-19 can
impact both physical and mental fatigue in the long term.
Furthermore, this study was conducted in adults, although
evidence regarding long COVID in children and adolescents is
starting to emerge [72,73].
Conclusions
Severe fatigue is highly prevalent in members of online long
COVID peer support groups both at approximately 3 and 6
months after onset of symptoms. As not enough time has passed
since the start of the COVID-19 pandemic, it is unclear whether
this fatigue will resolve spontaneously in the longer term. Future
research needs to focus on the prognosis, possible causes, and
treatment strategies for physical and mental fatigue in patients
with long COVID.
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